![Tim Coughlin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tim Coughlin
Chairman at
ATYR PHARMA, INC.
Net worth: 4 M $ as of 30/08/2026
Profile
Timothy P.
Coughlin is Chairman at aTyr Pharma, Inc. since 2024.
He is a Non-Executive Director at ADC Therapeutics SA starting in 2025.
He serves as an Independent Director at Travere Therapeutics, Inc. since 2015.
He is a Director at Vir Biotechnology, Inc. beginning in 2026.
Former roles include Independent Director at Fate Therapeutics, Inc. from 2015 to 2025, Director at Peloton Therapeutics, Inc. in 2019, Senior Manager-Health Sciences Practice at Ernst & Young LLP from 1989 to 1999, Chief Financial Officer at Neurocrine Biosciences, Inc., and Vice President-Financial Services at CommonSpirit Health from 1999 to 2002.
Education includes a graduate degree from San Diego State University conferred in 2002 and an undergraduate degree from Temple University (Pennsylvania) conferred in 1989.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 11/06/2026 | 56,250 ( 0.06% ) | 4 M $ | 30/08/2026 | |
ADC THERAPEUTICS LTD 0.06% | 02/06/2026 | 72,400 ( 0.06% ) | 84 708 $ | 30/08/2026 |
ATYR PHARMA, INC. 0.06% | 10/05/2026 | 56,000 ( 0.06% ) | 29 792 $ | 30/08/2026 |
Tim Coughlin active positions
| Companies | Position | Start |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Director/Board Member | 30/03/2015 |
| ATYR PHARMA, INC. | Chairman | 13/03/2024 |
| ADC THERAPEUTICS SA | Director/Board Member | 31/05/2025 |
| VIR BIOTECHNOLOGY, INC. | Director/Board Member | 08/06/2026 |
Former positions of Tim Coughlin
| Companies | Position | End |
|---|---|---|
| FATE THERAPEUTICS, INC. | Director/Board Member | 28/05/2025 |
| PELOTON THERAPEUTICS, INC. | Director/Board Member | 30/11/2019 |
CommonSpirit Health (Illinois)
 CommonSpirit Health (Illinois) Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit catholic health organization | Director of Finance/CFO | 31/12/2001 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | 31/12/1998 |
| NEUROCRINE BIOSCIENCES, INC. | Director of Finance/CFO | - |
Training of Tim Coughlin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
97
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
aTyr Pharma, Inc.
 aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
CommonSpirit Health (Illinois)
CommonSpirit Health (Illinois) Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit catholic health organization | Commercial Services |
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University (Pennsylvania)
 Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
- Stock Market
- Insiders
- Tim Coughlin
